An EMA advisory panel has rejected expanding the use of Eli Lilly’s Emgality to include prevention of episodic cluster headaches. The Committee for Medicinal Products for Human Use (CHMP ...
That puts Emgality ahead of Teva’s Ajovy (fremanezumab ... The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement ...
Migraine headaches may cause intense pulsing or throbbing pain, often on one side of the head. Four injectable prescription medications are available to prevent migraines in adults: Aimovig, Vyepti, ...